<?xml version="1.0" encoding="UTF-8"?>
<p id="Par10">The design and methods of the phase 3 PIX301 study have been described previously [
 <xref ref-type="bibr" rid="CR15">15</xref>]. Briefly, PIX301 was a multicenter, open-label, randomized trial [
 <xref ref-type="bibr" rid="CR15">15</xref>]. A total of 140Â patients were enrolled in 66 hospital centers in Europe, India, Russia, South America, UK and USA between October 2004 and March 2008. All patients provided written informed consent, and local ethical approval was obtained in all centers. The study was registered at ClinicalTrials.gov (NCT00088530).
</p>
